Clin2
NCT05229679Likely a fitRecruiting

HPV screening for women ages 23 to 29

Human Papilloma VirusCervical Intraepithelial NeoplasiaCervical Cancer

Part of Cancer, Women’s health & pregnancy clinical trials.

This study focuses on HPV-based screening for women ages 23–29. It may help confirm whether HPV testing is a good way to find early signs of cervical cancer risk in this age group.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
180,000 people
Ages
23 years to 29 years
Study type
Interventional

Who can take part

  • Be a woman between 23 and 29 years old
  • Be invited or eligible to join the screening program for your age group
  • Attend the screening appointment (show up)
  • Agree to participate by giving consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07593066Not yet recruiting
Cervical cancer screening study for women

This study looks at ways to improve cervical cancer screening for women. If you join, you may help researchers find better methods for early detection, which can lead to earlier treatment and better outcomes.

Coyhaique, Aysén
NCT07336134Recruiting
HPV self-test for cervical health

This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.

Philadelphia, Pennsylvania
NCT06042543Recruiting
Cervical cancer screening trial for unscreened women

This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.

Cincinnati, Ohio
NCT06815939Recruiting
A Simple, Lab-Free Test for Cervical Cancer

This trial is testing a new, low-cost, lab-free screening test for cervical cancer. The goal is to see if it can detect early signs of cancer without needing a doctor's visit or a lab — making it easier for women to get screened.

San Salvador
NCT04910802Recruiting· Phase 4
HPV vaccine with routine HPV screening for ages 22–26

This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.

Stockholm
NCT07657104Not yet recruiting
HPV screening for women in the emergency department

This study offers free HPV testing to women who visit the emergency department and haven't been screened recently. It aims to catch early signs of cervical cancer so they can get treated sooner.

New Brunswick, New Jersey

Hear when a new Human Papilloma Virus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.